|
|
527 Madison Avenue New York, NY 10022 USA phone:212-583-0100 fax:212-679-7999
|
|
| Symbol |
ENZ |
| Exchange |
NYSE |
| Founded |
1976 |
| Employees |
238 |
|
|
| www.enzo.com
|
|
| Research Sector |
Biotech Specialty Pharma |
|
 |
| Summary Description |
| Genetic processes to develop research tools, diagnostics and therapeutics. |
 |
| Management |
| Elazar Rabbani, Ph.D., Chairman of the Board of Directors & Chief Executive Officer; Barry W. Weiner, President and Director; Carl Balezentis, Ph.D., President , Enzo Life Sciences; Dr. Christine T. Fischette, President, Enzo Therapeutics; Kevin Krenitsky, MD, President, Enzo Clinical Labs, Inc |
| |
|
|
|
|
|
|
|
| Keywords |
| diagnostics, radioactive, immunological, autoimmune, hepatitis |
|
|
|
| Description |
|
Enzo Biochem, Inc. is a life sciences and biotechnology company focused on harnessing genetic processes to develop research tools, diagnostics and therapeutics. The Company also provides diagnostic services to the medical community. |
 |
| Products / Services |
Microarray Analysis, Nucleic Acid Labeling Systems, Modified Nucleotides, Monoclonal Antibodies, In Situ Hybridization And Detection Systems, Human Papillomavirus Identification Systems, Apoptosis In Situ Cell Death Assay Systems, BioProbe Labeled Probes, Signal Generating Systems
|
 |
| Technology / Differentiation |
| The Company has concentrated on developing enabling technologies for detecting and identifying genes and for modifying gene expression. These technologies are generally applicable for the diagnosis of infectious and other diseases, and form the basis for a portfolio of over 300 products marketed to the biomedical and pharmaceutical research markets. |
 |
 |
| Competitors / Substitutes / Alternatives |
Bio Reference Laboratories Inc (BRLI), Laboratory Corporation of America Holdings (LH), Quest Diagnostics Inc (DGX)
|
 |
|
|
|
|
|
|